Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families
- PMID: 11781689
- DOI: 10.1038/sj.ejhg.5200717
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families
Abstract
The 999del5 mutation is the single, strong BRCA2 founder mutation in Iceland and the most common BRCA1/2 founder mutation in Finland. To evaluate the origin and time since spreading of the 999del5 mutation in Iceland and in Finland, we constructed haplotypes with polymorphic markers within and flanking the BRCA2 gene in a set of 18 Icelandic and 10 Finnish 999del5 breast cancer families. All Icelandic families analysed shared a common core haplotype of about 1.7 cM. The common ancestors for the Icelandic families studied were estimated to trace back to 340-1000 years, not excluding the possibility that the mutation was brought to Iceland during the settlement of the country. Analysis of the Finnish families revealed two distinct haplotypes. A rare one, found in three families in the old settlement region in southwestern Finland, shared a four-marker (0.5 cM) core haplotype with the Icelandic 999del5 haplotype. A distinct approximately 6 cM haplotype was shared by seven 999del5 Finnish families estimated to have a common ancestry 140-300 years ago. These families cluster in two geographical regions in Finland, in the very same area as those with the rare haplotype and also in the most eastern, late settlement region of Finland. The results may indicate a common ancient origin for the 999del5 mutation in Iceland and in Finland, but distinct mutational events cannot be ruled out. The surprising finding of the same mutation in two completely different haplotypes in a sparsely populated area in Finland may suggest gene conversion.
Similar articles
-
Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.Clin Genet. 2007 Oct;72(4):311-20. doi: 10.1111/j.1399-0004.2007.00866.x. Clin Genet. 2007. PMID: 17850627
-
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.Eur J Hum Genet. 2000 Oct;8(10):757-63. doi: 10.1038/sj.ejhg.5200529. Eur J Hum Genet. 2000. PMID: 11039575
-
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.Nat Genet. 1996 May;13(1):117-9. doi: 10.1038/ng0596-117. Nat Genet. 1996. PMID: 8673089
-
Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2.Hum Mutat. 2002 Dec;20(6):413-24. doi: 10.1002/humu.10154. Hum Mutat. 2002. PMID: 12442265 Review.
-
Finnish Disease Heritage I: characteristics, causes, background.Hum Genet. 2003 May;112(5-6):441-56. doi: 10.1007/s00439-002-0875-3. Epub 2003 Mar 8. Hum Genet. 2003. PMID: 12627295 Review.
Cited by
-
A populationwide coalescent analysis of Icelandic matrilineal and patrilineal genealogies: evidence for a faster evolutionary rate of mtDNA lineages than Y chromosomes.Am J Hum Genet. 2003 Jun;72(6):1370-88. doi: 10.1086/375453. Epub 2003 Apr 29. Am J Hum Genet. 2003. PMID: 12721957 Free PMC article.
-
Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.Hum Genet. 2005 Jul;117(2-3):119-32. doi: 10.1007/s00439-005-1297-9. Epub 2005 May 10. Hum Genet. 2005. PMID: 15883839
-
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan.BMC Cancer. 2018 Feb 6;18(1):152. doi: 10.1186/s12885-018-4079-1. BMC Cancer. 2018. PMID: 29409476 Free PMC article.
-
A novel mutation in the TG gene (G2322S) causing congenital hypothyroidism in a Sudanese family: a case report.BMC Med Genet. 2018 May 2;19(1):69. doi: 10.1186/s12881-018-0588-7. BMC Med Genet. 2018. PMID: 29720101 Free PMC article.
-
Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland.Sci Rep. 2022 Apr 25;12(1):6704. doi: 10.1038/s41598-022-10519-y. Sci Rep. 2022. PMID: 35469032 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous